10-QPeriod: Q1 FY2022

SYNOPSYS INC Quarterly Report for Q1 Ended Jan 31, 2022

Filed February 18, 2022For Securities:SNPS

Summary

Synopsys Inc. reported robust financial performance for the quarter ended January 31, 2022, demonstrating significant year-over-year growth. Total revenue increased by 31% to $1.27 billion, driven by strong contributions from both the Semiconductor & System Design and Software Integrity segments. This revenue growth outpaced the increase in operating expenses, leading to a substantial rise in operating income by 134% to $347 million. The company also generated strong operating cash flow, underscoring its healthy financial position. Management expressed confidence in the company's ability to meet its financial requirements and capital return program, supported by existing liquidity and cash generated from operations. Key financial highlights include a significant increase in upfront product revenue, a 111% jump year-over-year, indicating strong demand for IP and hardware products. While time-based products revenue also grew, its percentage of total revenue decreased slightly. The company's strategic focus on innovation and market expansion continues to drive performance, with ongoing investments in research and development. Synopsys also actively manages its capital structure, evidenced by its share repurchase program, with $750 million remaining available for future repurchases as of the reporting date.

Financial Statements
Beta
Revenue$1.27B
Cost of Revenue$256.98M
Gross Profit$1.01B
R&D Expenses$383.97M
Operating Expenses$666.24M
Operating Income$347.04M
Interest Expense$500K
Net Income$313.69M
EPS (Basic)$2.05
EPS (Diluted)$1.99
Shares Outstanding (Basic)153.22M
Shares Outstanding (Diluted)157.27M

Key Highlights

  • 1Total revenue surged 31% year-over-year to $1.27 billion, fueled by broad-based growth across all product groups and geographies.
  • 2Operating income saw a substantial increase of 134% to $347 million, demonstrating strong operating leverage as revenue growth outpaced expense growth.
  • 3Upfront product revenue more than doubled, increasing by 111% to $368.3 million, indicating robust demand for IP and hardware offerings.
  • 4Time-based product revenue grew 12% to $707.5 million, reflecting the continued strength of its subscription-based offerings.
  • 5The company maintained a healthy adjusted operating margin of 36% overall, with the Semiconductor & System Design segment at 38% and the Software Integrity segment at 11%.
  • 6Synopsys generated $155.7 million in cash from operating activities, though this was a slight decrease from the prior year period due to timing of billings and disbursements.
  • 7The company continued its capital return program, repurchasing $245 million worth of stock during the quarter and having $750 million remaining under its authorized repurchase program.

Frequently Asked Questions

The substantial 31% increase in total revenue to $1.27 billion was driven by strong organic growth across all product groups and geographies. Specifically, the Semiconductor & System Design segment saw a 32% increase, while the Software Integrity segment grew by 17%. The upfront product revenue segment more than doubled, indicating robust demand for IP and hardware products.

Synopsys effectively managed its expenses, with total cost of revenue and operating expenses increasing by 12%, which was significantly lower than the 31% revenue growth. This resulted in a substantial improvement in operating income, which grew by 134% to $347 million. The company benefited from operating leverage, as revenue growth outpaced the growth in costs and expenses.

Synopsys maintains a strong liquidity position, with $1.27 billion in cash, cash equivalents, and short-term investments as of January 31, 2022. The company generated $155.7 million in cash from operating activities. Synopsys continues to return capital to shareholders, having repurchased $245 million of common stock during the quarter, and has $750 million remaining under its authorized stock repurchase program, indicating a continued commitment to shareholder returns.

The filing discusses various risks, including those related to the ongoing COVID-19 pandemic's impact on the global economy and supply chains, industry competition, cybersecurity threats, and potential disruptions from geopolitical events and trade restrictions, particularly concerning China. The company also highlighted a tax examination in Hungary as an ongoing legal matter.